Defunct Company
Total Trials
10
As Lead Sponsor
9
As Collaborator
1
Total Enrollment
2,819
NCT01743079
Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B
Phase: Phase 4
Role: Collaborator
Start: Jan 31, 2009
Completion: Jul 31, 2013
NCT01488526
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Role: Lead Sponsor
Start: Mar 1, 2012
Completion: Jun 28, 2018
NCT01715987
Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment
Phase: N/A
Start: Oct 31, 2012
Completion: May 31, 2016
NCT04839120
PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers
Phase: Phase 1
Start: Feb 21, 2017
Completion: Jun 7, 2017
NCT03476083
Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
Start: Jun 10, 2018
Completion: May 31, 2024
NCT04237376
Chronic HBV Infection in Pregnant Women Taking TAF to Prevent Vertical Transmission
Start: Apr 9, 2019
Completion: Sep 30, 2020
NCT04211805
Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B
Start: Jan 27, 2020
Completion: Sep 30, 2021
NCT04201808
Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides
Start: May 1, 2021
Completion: Sep 30, 2023
NCT05580107
MDPK67b in Patients With Prostate Cancer
Start: Aug 9, 2021
Completion: Jun 30, 2024
NCT06051669
Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US
Start: Sep 24, 2023
Completion: Mar 31, 2025